AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment
Retrieved on:
星期四, 二月 23, 2023
ARMC, Johnson & Johnson, Doctor of Philosophy, Cancer, Diagnosis, EGG, Lung nodule, NYSE, Disease, AtlantiCare, Partnership, Interventional pulmonology, Risk, Survival rate, FDA, Oncology, Patient, CT, Lung cancer, American Lung Association, Heart & Lung, JNJ, Biopsy, Neoplasm, AtlantiCare Regional Medical Center, Mainland Campus, UKCA, Physician, Medical imaging, Medical device, Ethicon, EU
EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ -- AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum's Virtual Nodule Clinic. Located in New Jersey, it is integrating the innovative technology into its early lung cancer diagnosis program at its Heart & Lung and Cancer Care institutes at AtlantiCare Regional Medical Center (ARMC).
Key Points:
- Located in New Jersey, it is integrating the innovative technology into its early lung cancer diagnosis program at its Heart & Lung and Cancer Care institutes at AtlantiCare Regional Medical Center (ARMC).
- Lung cancer is among the most common types of cancer and the leading cause of cancer deaths in the world, according to the American Lung Association .
- Optellum's integrated Lung Cancer Prediction capability also helps AtlantiCare clinicians prioritize patients at high risk of having lung cancer.
- "We have already identified suspicious tumors in individuals who have no known risk of lung cancer through this technology," added Borah.